Veristat
Southborough, Massachusetts, United States · Biotechnology, Health Care, Therapeutics
Veristat is the science-first full-service drug and biologic CRO and consultancy that integrates strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies. At Veristat, we collaborate with clients to support the rapid delivery of life-changing therapies, helping them make sound decisions amidst uncertainties. Our scientific ex
Key facts
- Headquarters
- Southborough, Massachusetts, United States
- Employees
- 500
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- www.veristat.com
- Company page
Recent activity at Veristat
- : Veristat Appoints Clint Wolfe as Chief Human Resources Officer
- : Veristat Appoints Kim McLean Boericke as Chief Executive Officer
- : Veristat Appoints Rachel Page as Chief Commercial Officer and Cindy Henderson as Chief Strategy Officer
- : Veristat Acquires European Medical Writing Consultancy Scinopsis
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Leadership
- Clint Wolfe, Chief Human Resources Officer
- Kim McLean Boericke, Chief Executive Officer
- Cindy Henderson, Chief Strategy Officer
Verified email and direct lines for Veristat’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Veristat files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Veristat in the news
- Veristat to Acquire Certara’s Regulatory and Medical Writing Business - Business Wire (Apr 22, 2026)
- Veristat Launches AI Biostatistics Platform, Cutting Clinical Trial Data Readout Time from 5 Weeks to 5 Days * Without Regulatory Risks - STT Info (May 13, 2026)
- Veristat Strengthens Biostatistics, Drug Development Advisory, and People Leadership to Support Growth in Complex Clinical Development - Business Wire (Jun 23, 2026)
- WindRose Health Investors Completes Recapitalization of Veristat Group Inc. - PR Newswire (Apr 07, 2021)
- Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application - Business Wire (Nov 12, 2026)
Companies similar to Veristat
- Amicus Therapeutics · Biotechnology, Health Care, Therapeutics
- Acadia Pharmaceuticals · Biotechnology, Health Care, Therapeutics
- Debiopharm · Biotechnology, Health Care, Therapeutics
- Travere Therapeutics · Biotechnology, Health Care, Therapeutics
- bluebird bio · Biotechnology, Health Care, Therapeutics
About Veristat: questions and answers
What does Veristat do?
Veristat is the science-first full-service drug and biologic CRO and consultancy that integrates strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies. At Veristat, we collaborate with clients to support the rapid delivery of life-changing therapies, helping them make sound decisions amidst uncertainties. Our scientific ex
Where is Veristat headquartered?
Veristat is headquartered in Southborough, Massachusetts, United States.
How many employees does Veristat have?
Veristat has about 500 employees.
Who leads Veristat?
Kim McLean Boericke is a Chief Executive Officer at Veristat.
What is the latest news on Veristat?
On Jun 23, 2026, Veristat Appoints Clint Wolfe as Chief Human Resources Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy